论文信息 - A phase I pharmacokinetic (PK) trial of XAA296A (Discodermolide) administered every 3 wks to adult patients with advanced solid malignancies. - 字舞流文

A phase I pharmacokinetic (PK) trial of XAA296A (Discodermolide) administered every 3 wks to adult patients with advanced solid malignancies.

A. Lockhart | A. Mita | E. Rowinsky | M. Rothenberg | L. Hammond | K. Bochinski | T.-L. Chen | W. Cooper | J. Curtright | S. Sharma | S. Sharma